RVL-002

N/A

Report date: 2024/01/10 11:07:26
NME

Base Information

Drug NameRVL-002
Drug Alias NameRVL-002RVL002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRett SyndromeFragile X SyndromeLeigh Disease +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesUnravel Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesUnravel Biosciences Inc
Inactive CompaniesN/A
Active IndicationsRett SyndromeFragile X SyndromeLeigh Disease +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A